Drug Discovery World

SEPTEMBER 6, 2022

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. The challenge for the market then, according to Boissel, is how much can a payor afford to pay upfront? . New indications .

Therapies 130

Therapies Clinical Trials Vaccine Disease 130

Codon

SEPTEMBER 29, 2024

But, regardless of which was first, they all operated with the same core data as their mechanism for understanding life: messenger RNA ( mRNA ). At best, the corporations with the best models released weak versions to the public under non-commercial licenses. There was scFormer in 2022, scGPT in 2023, and plenty of others.

Engineering 125

Engineering Virus DNA Therapies 125

Drug Discovery World

FEBRUARY 22, 2024

But psychopharmacology developments petered out, and few new drugs reached the market during the last four decades. The report also highlights that the global neuroscience market (GNM) “was worth $612 billion in 2022 and could grow to $721 billion by 2026.

Drugs 147

Drugs Clinical Trials Disease Therapies 147